Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention
<strong>Background</strong> Coronary artery disease (CAD) has substantial heritability and a polygenic architecture. However, the potential of genomic risk scores to help predict CAD outcomes has not been evaluated comprehensively, because available studies have involved limited genomic...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2018
|
| _version_ | 1797100728418828288 |
|---|---|
| author | Inouye, M Abraham, G Nelson, C Wood, A Sweeting, M Dudbridge, F Lai, F Kaptoge, S Brozynska, M Wang, T Ye, S Webb, T Rutter, M Tzoulaki, I Patel, R Loos, R Keavney, B Hemingway, H Thompson, J Watkins, H Deloukas, P Di Angelantonio, E Butterworth, A Danesh, J Samani, N UK Biobank CardioMetabolic Consortium CHD Working Group |
| author_facet | Inouye, M Abraham, G Nelson, C Wood, A Sweeting, M Dudbridge, F Lai, F Kaptoge, S Brozynska, M Wang, T Ye, S Webb, T Rutter, M Tzoulaki, I Patel, R Loos, R Keavney, B Hemingway, H Thompson, J Watkins, H Deloukas, P Di Angelantonio, E Butterworth, A Danesh, J Samani, N UK Biobank CardioMetabolic Consortium CHD Working Group |
| author_sort | Inouye, M |
| collection | OXFORD |
| description | <strong>Background</strong> Coronary artery disease (CAD) has substantial heritability and a polygenic architecture. However, the potential of genomic risk scores to help predict CAD outcomes has not been evaluated comprehensively, because available studies have involved limited genomic scope and limited sample sizes. <br/><br/> <strong>Objectives</strong> This study sought to construct a genomic risk score for CAD and to estimate its potential as a screening tool for primary prevention. <br/><br/> <strong>Methods</strong> Using a meta-analytic approach to combine large-scale, genome-wide, and targeted genetic association data, we developed a new genomic risk score for CAD (metaGRS) consisting of 1.7 million genetic variants. We externally tested metaGRS, both by itself and in combination with available data on conventional risk factors, in 22,242 CAD cases and 460,387 noncases from the UK Biobank. <br/><br/> <strong>Results</strong> The hazard ratio (HR) for CAD was 1.71 (95% confidence interval [CI]: 1.68 to 1.73) per SD increase in metaGRS, an association larger than any other externally tested genetic risk score previously published. The metaGRS stratified individuals into significantly different life course trajectories of CAD risk, with those in the top 20% of metaGRS distribution having an HR of 4.17 (95% CI: 3.97 to 4.38) compared with those in the bottom 20%. The corresponding HR was 2.83 (95% CI: 2.61 to 3.07) among individuals on lipid-lowering or antihypertensive medications. The metaGRS had a higher C-index (C = 0.623; 95% CI: 0.615 to 0.631) for incident CAD than any of 6 conventional factors (smoking, diabetes, hypertension, body mass index, self-reported high cholesterol, and family history). For men in the top 20% of metaGRS with >2 conventional factors, 10% cumulative risk of CAD was reached by 48 years of age. <br/><br/> <strong>Conclusions</strong> The genomic score developed and evaluated here substantially advances the concept of using genomic information to stratify individuals with different trajectories of CAD risk and highlights the potential for genomic screening in early life to complement conventional risk prediction. |
| first_indexed | 2024-03-07T05:41:45Z |
| format | Journal article |
| id | oxford-uuid:e5d0a552-a8ac-4e50-a6ae-8ccca41e00c2 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:41:45Z |
| publishDate | 2018 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:e5d0a552-a8ac-4e50-a6ae-8ccca41e00c22022-03-27T10:26:41ZGenomic risk prediction of coronary artery disease in 480,000 adults: implications for primary preventionJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e5d0a552-a8ac-4e50-a6ae-8ccca41e00c2EnglishSymplectic Elements at OxfordElsevier2018Inouye, MAbraham, GNelson, CWood, ASweeting, MDudbridge, FLai, FKaptoge, SBrozynska, MWang, TYe, SWebb, TRutter, MTzoulaki, IPatel, RLoos, RKeavney, BHemingway, HThompson, JWatkins, HDeloukas, PDi Angelantonio, EButterworth, ADanesh, JSamani, NUK Biobank CardioMetabolic Consortium CHD Working Group<strong>Background</strong> Coronary artery disease (CAD) has substantial heritability and a polygenic architecture. However, the potential of genomic risk scores to help predict CAD outcomes has not been evaluated comprehensively, because available studies have involved limited genomic scope and limited sample sizes. <br/><br/> <strong>Objectives</strong> This study sought to construct a genomic risk score for CAD and to estimate its potential as a screening tool for primary prevention. <br/><br/> <strong>Methods</strong> Using a meta-analytic approach to combine large-scale, genome-wide, and targeted genetic association data, we developed a new genomic risk score for CAD (metaGRS) consisting of 1.7 million genetic variants. We externally tested metaGRS, both by itself and in combination with available data on conventional risk factors, in 22,242 CAD cases and 460,387 noncases from the UK Biobank. <br/><br/> <strong>Results</strong> The hazard ratio (HR) for CAD was 1.71 (95% confidence interval [CI]: 1.68 to 1.73) per SD increase in metaGRS, an association larger than any other externally tested genetic risk score previously published. The metaGRS stratified individuals into significantly different life course trajectories of CAD risk, with those in the top 20% of metaGRS distribution having an HR of 4.17 (95% CI: 3.97 to 4.38) compared with those in the bottom 20%. The corresponding HR was 2.83 (95% CI: 2.61 to 3.07) among individuals on lipid-lowering or antihypertensive medications. The metaGRS had a higher C-index (C = 0.623; 95% CI: 0.615 to 0.631) for incident CAD than any of 6 conventional factors (smoking, diabetes, hypertension, body mass index, self-reported high cholesterol, and family history). For men in the top 20% of metaGRS with >2 conventional factors, 10% cumulative risk of CAD was reached by 48 years of age. <br/><br/> <strong>Conclusions</strong> The genomic score developed and evaluated here substantially advances the concept of using genomic information to stratify individuals with different trajectories of CAD risk and highlights the potential for genomic screening in early life to complement conventional risk prediction. |
| spellingShingle | Inouye, M Abraham, G Nelson, C Wood, A Sweeting, M Dudbridge, F Lai, F Kaptoge, S Brozynska, M Wang, T Ye, S Webb, T Rutter, M Tzoulaki, I Patel, R Loos, R Keavney, B Hemingway, H Thompson, J Watkins, H Deloukas, P Di Angelantonio, E Butterworth, A Danesh, J Samani, N UK Biobank CardioMetabolic Consortium CHD Working Group Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention |
| title | Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention |
| title_full | Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention |
| title_fullStr | Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention |
| title_full_unstemmed | Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention |
| title_short | Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention |
| title_sort | genomic risk prediction of coronary artery disease in 480 000 adults implications for primary prevention |
| work_keys_str_mv | AT inouyem genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT abrahamg genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT nelsonc genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT wooda genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT sweetingm genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT dudbridgef genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT laif genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT kaptoges genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT brozynskam genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT wangt genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT yes genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT webbt genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT rutterm genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT tzoulakii genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT patelr genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT loosr genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT keavneyb genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT hemingwayh genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT thompsonj genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT watkinsh genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT deloukasp genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT diangelantonioe genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT butterwortha genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT daneshj genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT samanin genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention AT ukbiobankcardiometabolicconsortiumchdworkinggroup genomicriskpredictionofcoronaryarterydiseasein480000adultsimplicationsforprimaryprevention |